Theravance Biopharma Inc (TBPH)
Sales/Maturities of Investments
$41.50M
Quarterly · Period ending: · USD
TBPH Sales/Maturities of Investments
Latest reported$41.50Mperiod ending
Latest reported$41.50Mperiod ending
TBPH Quarterly Sales/Maturities of Investments ($0.00 → $41.50M)
Quarterly Sales/Maturities of Investments
High-resolution chart · PNG
TBPH sales/maturities of investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 41,496,000 | |
| 96,000,000 | |
| 65,525,000 | |
| 24,500,000 | |
| 20,350,000 | |
| 32,600,000 | |
| 55,889,000 | |
| 27,498,000 | |
| 28,243,000 | |
| 44,021,000 | |
| 0 | |
| 0 | |
| 10,597,000 | |
| 92,215,000 | |
| 49,312,000 | |
| 17,006,000 | |
| 43,200,000 | |
| 48,499,000 | |
| 64,799,000 | |
| 30,000,000 | |
| 75,900,000 | |
| 115,500,000 | |
| 118,014,000 | |
| 125,616,000 | |
| 41,495,000 | |
| 134,135,000 | |
| 0 | |
| 134,800,000 | |
| 54,170,000 | |
| 77,198,000 | |
| 97,742,000 | |
| 113,022,000 | |
| 90,129,000 | |
| 46,299,000 | |
| 44,475,000 | |
| 69,419,000 | |
| 84,688,000 | |
| 36,282,000 | |
| 23,203,000 | |
| 27,750,000 | |
| 23,445,000 | |
| 17,069,000 | |
| 28,055,000 | |
| 62,763,000 | |
| 42,409,000 | |
| 53,470,000 | |
| 34,166,000 | |
| 26,493,000 | |
| 5,783,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |